Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States.

ABSTRACT:

Introduction

Lupus nephritis (LN) treatment aims to control and prevent flares and irreversible kidney damage. Around 30% of patients are unresponsive to treatment; however, real-world LN treatment patterns have not been reported. Objectives of this retrospective cohort study (GSK 209758) were to quantify the time to switching/re-initiating induction therapy in patients with LN initiating immunosuppressant therapy and conversion from induction to maintenance immunosuppressant therapy, and to assess corticosteroid use.

Methods

Patients with LN initiating induction or maintenance immunosuppressant therapy were identified using claims data. Patients were followed up from the index date (immunosuppressant initiation date) until treatment discontinuation, death, disenrollment, ad

SUBMITTER: Hunnicutt JN 

PROVIDER: S-EPMC10468458 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature